Mid-Term Outcomes of Percutaneous Treatment of Superficial Femoral Artery Total Occlusions: Single Center Experience

Objectives: Superficial femoral artery is the most commonly effected vessel in peripheral arterial disease and superficial femoral artery total occlusions constitute the 50% of peripheral arterial disease patients presenting with symptoms. In this study, we investigated our patients with superficial femoral artery total occlusions who were treated with percutaneous treatment strategy. Materials and Methods: In this study, we included ambulatory patients who were admitted to our clinics due to symptomatic severe superficial femoral artery total occlusion and underwent percutaneous transluminal angioplasty or underwent percutaneous transluminal angioplasty + stenting procedure. The demographic findings of the patients, procedure details, complications and follow-up results were noted. Results: Out of 67 patients, 62 (92.5%) underwent percutaneous transluminal angioplasty or percutaneous transluminal angioplasty + stenting procedure successfully for superficial femoral artery total occlusions. Only one serious complication, acute renal failure resulting in death developed during hospitalization. The mean follow-up time after the procedure was 11.1±7.2 months. During this follow-up time 36 (58.1%) were asymptomatic. Out of 26 patients who were symptomatic, only 6 of them underwent reintervention and 3 were recommended surgical intervention. Conclusion: Peripheral interventions for superficial femoral artery total occlusions are being performed successfully in experienced centers with low complication rates as the first treatment strategy in peripheral arterial disease. Herein, we have presented our patients who underwent successful percutaneous transluminal angioplasty and/or stenting procedure with high success and low complication rates. Peripheral interventions should be the first choice for superficial femoral artery superficial femoral artery total occlusions in experienced centers.